(1)
Follow-up Results of a Randomized, Double-Blind, Phase III, Multi-Center Study to Evaluate the Safety and Efficacy of BF-200 ALA Versus Placebo in Field-Directed Treatment of Mild to Moderate AK With Photodynamic Therapy When Using Narrowband Red Light. J of Skin 2019, 3, S49. https://doi.org/10.25251/skin.3.supp.49.